PMID: 18724043Aug 30, 2008Paper

Hyperleptinemia as a robust risk factor of coronary artery disease and metabolic syndrome in type 2 diabetic patients

Endocrine Journal
Soo-Kyung KimBong-Soo Cha

Abstract

Leptin has been linked to adiposity, insulin resistance, and coronary artery disease (CAD). We examined whether the leptin concentrations are associated with the risk of CAD and metabolic syndrome (MS). The plasma leptin concentrations were measured in 556 diabetic patients (341 men and 215 women). The odds ratio (OR) of CAD and MS were increased on moving from the lowest quartile (Q1) of leptin concentration to the highest quartile (Q4) and remained significant after adjusting for age, sex, BMI, concentrations of total cholesterol, triglyceride, or high-sensitivity C-reactive protein (hsCRP), and treatment modalities for hyperglycemia. The frequency of CAD was highest in the insulin resistant group (Q4 of homeostasis model assessment-insulin resistance index [HOMA-IR]) at Q4 of leptin concentration (34.5%), compared with that of Q4 of leptin (26.4%) or HOMA-IR (21.9%). In multivariate analysis, plasma leptin concentration was identified as the most significantly independent predictor for CAD (OR 10.24, 95% CI 3.01 to 45.05). Other variables with associated with CAD were age, sex, hypertension, low-HDL cholesterolemia, and hsCRP. In conclusion, hyperleptinemia might be an independent risk factor for CAD and MS in diabetic subje...Continue Reading

References

Sep 1, 1995·Nature Medicine·F LönnqvistM Schalling
May 1, 1994·Metabolism: Clinical and Experimental·P M NishinaB Paigen
Jul 15, 1997·The Journal of Clinical Investigation·W G HaynesW I Sivitz
Jul 1, 1997·The American Journal of Physiology·P J ScarpaceN Tümer
Mar 21, 1998·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·P Z ZimmetD Fareed
Jun 20, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·F LeyvaJ C Stevenson
Jun 10, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·K HottaY Matsuzawa
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Mar 9, 2002·Current Hypertension Reports·Kamal RahmouniAllyn L Mark
Apr 3, 2002·JAMA : the Journal of the American Medical Association·Peter F BodaryDaniel T Eitzman
Nov 15, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Katrin SchäferStavros Konstantinides
Aug 5, 2004·The Journal of Clinical Endocrinology and Metabolism·Muredach P ReillyStephen E Kimmel
Nov 3, 2004·Journal of the American College of Cardiology·Robert WolkVirend K Somers
May 27, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·H-P KoppG Schernthaner
Aug 23, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Stefan PilzUNKNOWN LUdwigshafen RIsk and Cardiovascular Health (LURIC) Group
Jul 12, 2008·Journal of the American College of Cardiology·Atif QasimMuredach P Reilly

❮ Previous
Next ❯

Citations

Jan 6, 2011·Rejuvenation Research·Víctor Manuel Mendoza-NúñezRosa Elba Galván-Duarte
Nov 12, 2013·Metabolic Syndrome and Related Disorders·Ali A RizviNicola Abate
Feb 25, 2009·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Stephen B Sondike, Jaime Jeffrey
Mar 20, 2010·Clinical Transplantation·Ming-Che LeeBang-Gee Hsu
Mar 4, 2011·The Journal of Clinical Hypertension·Ryoko MitsutakeKeijiro Saku
Jul 14, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A P van de WoestijneF L J Visseren
Mar 13, 2014·Geriatrics & Gerontology International·Malgorzata Roszkowska-GancarzMonika Puzianowska-Kuznicka
Oct 13, 2011·Angiology·Niki KatsikiDimitrios T Karamitsos
Jan 4, 2018·Ci Ji Yi Xue Za Zhi = Tzu-chi Medical Journal·Jen-Pi Tsai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.